nodes	percent_of_prediction	percent_of_DWPC	metapath
Pranlukast—TNF—acquired immunodeficiency syndrome	0.393	1	CbGaD
Pranlukast—ABCC2—Indinavir—acquired immunodeficiency syndrome	0.0485	0.109	CbGbCtD
Pranlukast—ABCC2—Saquinavir—acquired immunodeficiency syndrome	0.0426	0.0959	CbGbCtD
Pranlukast—ABCC2—Ritonavir—acquired immunodeficiency syndrome	0.0426	0.0959	CbGbCtD
Pranlukast—ABCC2—Lamivudine—acquired immunodeficiency syndrome	0.0316	0.0712	CbGbCtD
Pranlukast—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0222	0.05	CbGbCtD
Pranlukast—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0209	0.047	CbGbCtD
Pranlukast—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0209	0.047	CbGbCtD
Pranlukast—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0189	0.0425	CbGbCtD
Pranlukast—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0189	0.0425	CbGbCtD
Pranlukast—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0163	0.0367	CbGbCtD
Pranlukast—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0158	0.0356	CbGbCtD
Pranlukast—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0143	0.0322	CbGbCtD
Pranlukast—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0143	0.0322	CbGbCtD
Pranlukast—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0137	0.0309	CbGbCtD
Pranlukast—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0129	0.0291	CbGbCtD
Pranlukast—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0121	0.0273	CbGbCtD
Pranlukast—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0121	0.0273	CbGbCtD
Pranlukast—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.011	0.0247	CbGbCtD
Pranlukast—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.011	0.0247	CbGbCtD
Pranlukast—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00947	0.0213	CbGbCtD
Pranlukast—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00919	0.0207	CbGbCtD
Pranlukast—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00831	0.0187	CbGbCtD
Pranlukast—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00831	0.0187	CbGbCtD
Pranlukast—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00797	0.018	CbGbCtD
Pranlukast—RNASE3—blood plasma—acquired immunodeficiency syndrome	0.00759	0.109	CbGeAlD
Pranlukast—RNASE3—lymphoid tissue—acquired immunodeficiency syndrome	0.00295	0.0424	CbGeAlD
Pranlukast—RNASE3—digestive system—acquired immunodeficiency syndrome	0.00292	0.0419	CbGeAlD
Pranlukast—RNASE3—blood—acquired immunodeficiency syndrome	0.00278	0.0399	CbGeAlD
Pranlukast—RNASE3—bone marrow—acquired immunodeficiency syndrome	0.00269	0.0386	CbGeAlD
Pranlukast—IL5—lymphoid tissue—acquired immunodeficiency syndrome	0.00268	0.0385	CbGeAlD
Pranlukast—IL5—digestive system—acquired immunodeficiency syndrome	0.00265	0.0381	CbGeAlD
Pranlukast—IL5—blood—acquired immunodeficiency syndrome	0.00252	0.0363	CbGeAlD
Pranlukast—RNASE3—lung—acquired immunodeficiency syndrome	0.00244	0.035	CbGeAlD
Pranlukast—IL5—lung—acquired immunodeficiency syndrome	0.00221	0.0318	CbGeAlD
Pranlukast—MUC2—digestive system—acquired immunodeficiency syndrome	0.00204	0.0293	CbGeAlD
Pranlukast—TNF—blood—acquired immunodeficiency syndrome	0.00194	0.0279	CbGeAlD
Pranlukast—MUC2—spinal cord—acquired immunodeficiency syndrome	0.00187	0.0269	CbGeAlD
Pranlukast—TNF—vagina—acquired immunodeficiency syndrome	0.0018	0.0258	CbGeAlD
Pranlukast—MUC2—lung—acquired immunodeficiency syndrome	0.0017	0.0244	CbGeAlD
Pranlukast—MUC2—nervous system—acquired immunodeficiency syndrome	0.00158	0.0226	CbGeAlD
Pranlukast—MUC2—central nervous system—acquired immunodeficiency syndrome	0.00152	0.0218	CbGeAlD
Pranlukast—IL5—lymph node—acquired immunodeficiency syndrome	0.00151	0.0217	CbGeAlD
Pranlukast—MUC2—brain—acquired immunodeficiency syndrome	0.0012	0.0173	CbGeAlD
Pranlukast—NFKB1—lymphoid tissue—acquired immunodeficiency syndrome	0.00118	0.0169	CbGeAlD
Pranlukast—TNF—lymph node—acquired immunodeficiency syndrome	0.00116	0.0167	CbGeAlD
Pranlukast—NFKB1—digestive system—acquired immunodeficiency syndrome	0.00116	0.0167	CbGeAlD
Pranlukast—CYSLTR1—lymphoid tissue—acquired immunodeficiency syndrome	0.00116	0.0166	CbGeAlD
Pranlukast—NFKB1—blood—acquired immunodeficiency syndrome	0.00111	0.0159	CbGeAlD
Pranlukast—CYSLTR1—blood—acquired immunodeficiency syndrome	0.00109	0.0156	CbGeAlD
Pranlukast—NFKB1—bone marrow—acquired immunodeficiency syndrome	0.00107	0.0154	CbGeAlD
Pranlukast—CYSLTR1—bone marrow—acquired immunodeficiency syndrome	0.00105	0.0151	CbGeAlD
Pranlukast—NFKB1—vagina—acquired immunodeficiency syndrome	0.00103	0.0147	CbGeAlD
Pranlukast—CYSLTR1—vagina—acquired immunodeficiency syndrome	0.00101	0.0145	CbGeAlD
Pranlukast—NFKB1—lung—acquired immunodeficiency syndrome	0.00097	0.0139	CbGeAlD
Pranlukast—CYSLTR1—lung—acquired immunodeficiency syndrome	0.000953	0.0137	CbGeAlD
Pranlukast—NFKB1—nervous system—acquired immunodeficiency syndrome	0.000899	0.0129	CbGeAlD
Pranlukast—CYSLTR1—nervous system—acquired immunodeficiency syndrome	0.000883	0.0127	CbGeAlD
Pranlukast—NFKB1—central nervous system—acquired immunodeficiency syndrome	0.000865	0.0124	CbGeAlD
Pranlukast—CYSLTR1—central nervous system—acquired immunodeficiency syndrome	0.00085	0.0122	CbGeAlD
Pranlukast—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.00079	0.0113	CbGeAlD
Pranlukast—NFKB1—brain—acquired immunodeficiency syndrome	0.000687	0.00986	CbGeAlD
Pranlukast—CYSLTR1—brain—acquired immunodeficiency syndrome	0.000675	0.00969	CbGeAlD
Pranlukast—NFKB1—lymph node—acquired immunodeficiency syndrome	0.000664	0.00953	CbGeAlD
Pranlukast—CYSLTR1—lymph node—acquired immunodeficiency syndrome	0.000652	0.00936	CbGeAlD
Pranlukast—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000603	0.00865	CbGeAlD
Pranlukast—ABCC2—digestive system—acquired immunodeficiency syndrome	0.000456	0.00655	CbGeAlD
Pranlukast—ABCC2—blood—acquired immunodeficiency syndrome	0.000435	0.00624	CbGeAlD
Pranlukast—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000304	0.00436	CbGeAlD
Pranlukast—CYP2C9—blood—acquired immunodeficiency syndrome	0.000289	0.00416	CbGeAlD
Pranlukast—ABCC2—lymph node—acquired immunodeficiency syndrome	0.000261	0.00374	CbGeAlD
Pranlukast—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000232	0.00333	CbGeAlD
Pranlukast—CYP3A4—blood—acquired immunodeficiency syndrome	0.000221	0.00317	CbGeAlD
Pranlukast—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000179	0.00257	CbGeAlD
Pranlukast—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000173	0.00248	CbGeAlD
Pranlukast—TNF—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	0.000161	0.00172	CbGpPWpGaD
Pranlukast—NFKB1—Folate Metabolism—IFNG—acquired immunodeficiency syndrome	0.000159	0.0017	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of Telomerase—IFNG—acquired immunodeficiency syndrome	0.000155	0.00166	CbGpPWpGaD
Pranlukast—NFKB1—IL12-mediated signaling events—IL2—acquired immunodeficiency syndrome	0.000152	0.00163	CbGpPWpGaD
Pranlukast—TNF—Transcription factor regulation in adipogenesis—IL6—acquired immunodeficiency syndrome	0.000152	0.00163	CbGpPWpGaD
Pranlukast—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—acquired immunodeficiency syndrome	0.000151	0.00161	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of toll-like receptor signaling pathway—CCL5—acquired immunodeficiency syndrome	0.000149	0.0016	CbGpPWpGaD
Pranlukast—IL5—Immune System—ACTG1—acquired immunodeficiency syndrome	0.000149	0.00159	CbGpPWpGaD
Pranlukast—TNF—Vitamin B12 Metabolism—IFNG—acquired immunodeficiency syndrome	0.000149	0.00159	CbGpPWpGaD
Pranlukast—NFKB1—amb2 Integrin signaling—IL6—acquired immunodeficiency syndrome	0.000148	0.00158	CbGpPWpGaD
Pranlukast—NFKB1—TWEAK Signaling Pathway—TNF—acquired immunodeficiency syndrome	0.000147	0.00158	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000147	0.00157	CbGpPWpGaD
Pranlukast—TNF—Toll-like Receptor Signaling Pathway—CCL5—acquired immunodeficiency syndrome	0.000146	0.00156	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000145	0.00155	CbGpPWpGaD
Pranlukast—TNF—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	0.000143	0.00153	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—IFNA1—acquired immunodeficiency syndrome	0.000143	0.00153	CbGpPWpGaD
Pranlukast—TNF—TGF-beta Receptor Signaling—IFNG—acquired immunodeficiency syndrome	0.000142	0.00152	CbGpPWpGaD
Pranlukast—NFKB1—Folate Metabolism—IL2—acquired immunodeficiency syndrome	0.000141	0.00151	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—CD79A—acquired immunodeficiency syndrome	0.000139	0.00149	CbGpPWpGaD
Pranlukast—NFKB1—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	0.000138	0.00148	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000138	0.00147	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000138	0.00147	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000138	0.00147	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of Telomerase—IL2—acquired immunodeficiency syndrome	0.000138	0.00147	CbGpPWpGaD
Pranlukast—IL5—Signaling by Interleukins—IL6—acquired immunodeficiency syndrome	0.000137	0.00147	CbGpPWpGaD
Pranlukast—NFKB1—TNF receptor signaling pathway —TNF—acquired immunodeficiency syndrome	0.000137	0.00147	CbGpPWpGaD
Pranlukast—NFKB1—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	0.000137	0.00147	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—IL10—acquired immunodeficiency syndrome	0.000136	0.00145	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000135	0.00144	CbGpPWpGaD
Pranlukast—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—acquired immunodeficiency syndrome	0.000134	0.00143	CbGpPWpGaD
Pranlukast—NFKB1—Glucocorticoid receptor regulatory network—IFNG—acquired immunodeficiency syndrome	0.000133	0.00143	CbGpPWpGaD
Pranlukast—TNF—IL27-mediated signaling events—IL6—acquired immunodeficiency syndrome	0.000133	0.00142	CbGpPWpGaD
Pranlukast—NFKB1—Ceramide signaling pathway—TNF—acquired immunodeficiency syndrome	0.000132	0.00142	CbGpPWpGaD
Pranlukast—TNF—Folate Metabolism—ALB—acquired immunodeficiency syndrome	0.000132	0.00142	CbGpPWpGaD
Pranlukast—IL5—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	0.000132	0.00141	CbGpPWpGaD
Pranlukast—NFKB1—IL23-mediated signaling events—IL6—acquired immunodeficiency syndrome	0.000132	0.00141	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000131	0.0014	CbGpPWpGaD
Pranlukast—TNF—Cytokines and Inflammatory Response—IL6—acquired immunodeficiency syndrome	0.000129	0.00138	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—CSF2—acquired immunodeficiency syndrome	0.000129	0.00138	CbGpPWpGaD
Pranlukast—NFKB1—Angiopoietin receptor Tie2-mediated signaling—TNF—acquired immunodeficiency syndrome	0.000128	0.00137	CbGpPWpGaD
Pranlukast—NFKB1—Vitamin B12 Metabolism—TNF—acquired immunodeficiency syndrome	0.000126	0.00135	CbGpPWpGaD
Pranlukast—NFKB1—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	0.000126	0.00135	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—IL4—acquired immunodeficiency syndrome	0.000126	0.00134	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000124	0.00133	CbGpPWpGaD
Pranlukast—IL5—Cytokine Signaling in Immune system—IFNG—acquired immunodeficiency syndrome	0.000123	0.00131	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—acquired immunodeficiency syndrome	0.000122	0.00131	CbGpPWpGaD
Pranlukast—IL5—Immune System—MBL2—acquired immunodeficiency syndrome	0.000122	0.00131	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000122	0.0013	CbGpPWpGaD
Pranlukast—TNF—Folate Metabolism—IFNG—acquired immunodeficiency syndrome	0.000121	0.00129	CbGpPWpGaD
Pranlukast—TNF—Downstream signaling in naïve CD8+ T cells—IFNG—acquired immunodeficiency syndrome	0.000121	0.00129	CbGpPWpGaD
Pranlukast—NFKB1—TGF-beta Receptor Signaling—TNF—acquired immunodeficiency syndrome	0.000121	0.00129	CbGpPWpGaD
Pranlukast—NFKB1—TCR Signaling Pathway—CD4—acquired immunodeficiency syndrome	0.00012	0.00128	CbGpPWpGaD
Pranlukast—NFKB1—TWEAK Signaling Pathway—IL6—acquired immunodeficiency syndrome	0.000119	0.00127	CbGpPWpGaD
Pranlukast—NFKB1—Cardiac Hypertrophic Response—TNF—acquired immunodeficiency syndrome	0.000119	0.00127	CbGpPWpGaD
Pranlukast—NFKB1—Glucocorticoid receptor regulatory network—IL2—acquired immunodeficiency syndrome	0.000118	0.00127	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—ACTG1—acquired immunodeficiency syndrome	0.000117	0.00126	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000116	0.00124	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000115	0.00123	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—CCL5—acquired immunodeficiency syndrome	0.000114	0.00122	CbGpPWpGaD
Pranlukast—TNF—amb2 Integrin signaling—IL6—acquired immunodeficiency syndrome	0.000113	0.0012	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000111	0.00118	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000111	0.00118	CbGpPWpGaD
Pranlukast—IL5—Cytokine Signaling in Immune system—IL2—acquired immunodeficiency syndrome	0.000109	0.00117	CbGpPWpGaD
Pranlukast—NFKB1—TSLP Signaling Pathway—IL6—acquired immunodeficiency syndrome	0.000109	0.00116	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000109	0.00116	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000109	0.00116	CbGpPWpGaD
Pranlukast—NFKB1—Corticotropin-releasing hormone—IL2—acquired immunodeficiency syndrome	0.000108	0.00116	CbGpPWpGaD
Pranlukast—TNF—Folate Metabolism—IL2—acquired immunodeficiency syndrome	0.000107	0.00115	CbGpPWpGaD
Pranlukast—TNF—Downstream signaling in naïve CD8+ T cells—IL2—acquired immunodeficiency syndrome	0.000107	0.00115	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—IFNA1—acquired immunodeficiency syndrome	0.000107	0.00115	CbGpPWpGaD
Pranlukast—TNF—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	0.000105	0.00112	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000105	0.00112	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000105	0.00112	CbGpPWpGaD
Pranlukast—TNF—Allograft Rejection—IFNG—acquired immunodeficiency syndrome	0.000105	0.00112	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—ACTG1—acquired immunodeficiency syndrome	0.000104	0.00111	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—IL10—acquired immunodeficiency syndrome	0.000103	0.0011	CbGpPWpGaD
Pranlukast—NFKB1—Folate Metabolism—TNF—acquired immunodeficiency syndrome	0.000103	0.0011	CbGpPWpGaD
Pranlukast—NFKB1—Vitamin B12 Metabolism—IL6—acquired immunodeficiency syndrome	0.000102	0.00109	CbGpPWpGaD
Pranlukast—TNF—IL23-mediated signaling events—IL6—acquired immunodeficiency syndrome	0.0001	0.00107	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.0001	0.00107	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	9.85e-05	0.00105	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	9.85e-05	0.00105	CbGpPWpGaD
Pranlukast—NFKB1—Signaling events mediated by HDAC Class I—TNF—acquired immunodeficiency syndrome	9.79e-05	0.00105	CbGpPWpGaD
Pranlukast—TNF—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	9.6e-05	0.00103	CbGpPWpGaD
Pranlukast—IL5—Immune System—CCR2—acquired immunodeficiency syndrome	9.58e-05	0.00102	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by Interleukins—IL2—acquired immunodeficiency syndrome	9.5e-05	0.00102	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	9.44e-05	0.00101	CbGpPWpGaD
Pranlukast—TNF—Allograft Rejection—IL2—acquired immunodeficiency syndrome	9.3e-05	0.000994	CbGpPWpGaD
Pranlukast—NFKB1—Transcriptional regulation of white adipocyte differentiation—TNF—acquired immunodeficiency syndrome	9.07e-05	0.00097	CbGpPWpGaD
Pranlukast—TNF—TWEAK Signaling Pathway—IL6—acquired immunodeficiency syndrome	9.06e-05	0.000969	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—ACTG1—acquired immunodeficiency syndrome	8.94e-05	0.000956	CbGpPWpGaD
Pranlukast—IL5—Immune System—IFNA1—acquired immunodeficiency syndrome	8.62e-05	0.000922	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—MBL2—acquired immunodeficiency syndrome	8.52e-05	0.000911	CbGpPWpGaD
Pranlukast—NFKB1—MicroRNAs in cardiomyocyte hypertrophy—TNF—acquired immunodeficiency syndrome	8.46e-05	0.000905	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis—TNF—acquired immunodeficiency syndrome	8.46e-05	0.000905	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—CSF2—acquired immunodeficiency syndrome	8.39e-05	0.000897	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—ALB—acquired immunodeficiency syndrome	8.38e-05	0.000897	CbGpPWpGaD
Pranlukast—IL5—Immune System—CD79A—acquired immunodeficiency syndrome	8.37e-05	0.000895	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	8.32e-05	0.000889	CbGpPWpGaD
Pranlukast—NFKB1—Folate Metabolism—IL6—acquired immunodeficiency syndrome	8.28e-05	0.000886	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	8.28e-05	0.000886	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	8.25e-05	0.000883	CbGpPWpGaD
Pranlukast—NFKB1—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	8.16e-05	0.000872	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	8.13e-05	0.000869	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—HLA-B—acquired immunodeficiency syndrome	8.07e-05	0.000863	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	7.95e-05	0.00085	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	7.95e-05	0.00085	CbGpPWpGaD
Pranlukast—NFKB1—TNF alpha Signaling Pathway—TNF—acquired immunodeficiency syndrome	7.87e-05	0.000842	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	7.79e-05	0.000833	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	7.79e-05	0.000833	CbGpPWpGaD
Pranlukast—TNF—Vitamin B12 Metabolism—IL6—acquired immunodeficiency syndrome	7.76e-05	0.000829	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—IFNG—acquired immunodeficiency syndrome	7.59e-05	0.000812	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	7.52e-05	0.000804	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	7.5e-05	0.000802	CbGpPWpGaD
Pranlukast—NFKB1—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—acquired immunodeficiency syndrome	7.48e-05	0.0008	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	7.44e-05	0.000795	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	7.43e-05	0.000795	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	7.38e-05	0.00079	CbGpPWpGaD
Pranlukast—NFKB1—Toll-like Receptor Signaling Pathway—TNF—acquired immunodeficiency syndrome	7.25e-05	0.000775	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	7.19e-05	0.000769	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	7.07e-05	0.000756	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	7.07e-05	0.000756	CbGpPWpGaD
Pranlukast—NFKB1—Glucocorticoid receptor regulatory network—IL6—acquired immunodeficiency syndrome	6.96e-05	0.000745	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	6.85e-05	0.000732	CbGpPWpGaD
Pranlukast—IL5—Immune System—CD40LG—acquired immunodeficiency syndrome	6.82e-05	0.00073	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—IL2—acquired immunodeficiency syndrome	6.8e-05	0.000727	CbGpPWpGaD
Pranlukast—NFKB1—MyD88 cascade initiated on plasma membrane—IL6—acquired immunodeficiency syndrome	6.77e-05	0.000723	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	6.75e-05	0.000722	CbGpPWpGaD
Pranlukast—IL5—Immune System—CD8A—acquired immunodeficiency syndrome	6.75e-05	0.000721	CbGpPWpGaD
Pranlukast—IL5—Immune System—CSF2—acquired immunodeficiency syndrome	6.75e-05	0.000721	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—IL2—acquired immunodeficiency syndrome	6.75e-05	0.000721	CbGpPWpGaD
Pranlukast—NFKB1—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—acquired immunodeficiency syndrome	6.7e-05	0.000717	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—CCR2—acquired immunodeficiency syndrome	6.68e-05	0.000714	CbGpPWpGaD
Pranlukast—NFKB1—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	6.58e-05	0.000704	CbGpPWpGaD
Pranlukast—NFKB1—MyD88 dependent cascade initiated on endosome—IL6—acquired immunodeficiency syndrome	6.58e-05	0.000704	CbGpPWpGaD
Pranlukast—IL5—Immune System—HLA-B—acquired immunodeficiency syndrome	6.49e-05	0.000694	CbGpPWpGaD
Pranlukast—NFKB1—TCR Signaling Pathway—IL6—acquired immunodeficiency syndrome	6.46e-05	0.000691	CbGpPWpGaD
Pranlukast—IL5—Cytokine Signaling in Immune system—IL6—acquired immunodeficiency syndrome	6.42e-05	0.000686	CbGpPWpGaD
Pranlukast—NFKB1—Toll Like Receptor 9 (TLR9) Cascade—IL6—acquired immunodeficiency syndrome	6.35e-05	0.000679	CbGpPWpGaD
Pranlukast—NFKB1—TNF alpha Signaling Pathway—IL6—acquired immunodeficiency syndrome	6.35e-05	0.000679	CbGpPWpGaD
Pranlukast—TNF—Folate Metabolism—IL6—acquired immunodeficiency syndrome	6.31e-05	0.000675	CbGpPWpGaD
Pranlukast—NFKB1—MyD88:Mal cascade initiated on plasma membrane—IL6—acquired immunodeficiency syndrome	6.24e-05	0.000668	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	6.19e-05	0.000662	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—ACTG1—acquired immunodeficiency syndrome	6.04e-05	0.000646	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—IFNA1—acquired immunodeficiency syndrome	6.01e-05	0.000643	CbGpPWpGaD
Pranlukast—NFKB1—MyD88-independent cascade—IL6—acquired immunodeficiency syndrome	5.99e-05	0.00064	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	5.92e-05	0.000633	CbGpPWpGaD
Pranlukast—NFKB1—Toll-like Receptor Signaling Pathway—IL6—acquired immunodeficiency syndrome	5.85e-05	0.000625	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	5.84e-05	0.000624	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	5.82e-05	0.000622	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	5.82e-05	0.000622	CbGpPWpGaD
Pranlukast—NFKB1—Senescence-Associated Secretory Phenotype (SASP)—IL6—acquired immunodeficiency syndrome	5.71e-05	0.000611	CbGpPWpGaD
Pranlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	5.69e-05	0.000608	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of toll-like receptor signaling pathway—TNF—acquired immunodeficiency syndrome	5.66e-05	0.000605	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—CD79A—acquired immunodeficiency syndrome	5.61e-05	0.0006	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by Interleukins—IL6—acquired immunodeficiency syndrome	5.59e-05	0.000597	CbGpPWpGaD
Pranlukast—NFKB1—Activated TLR4 signalling—IL6—acquired immunodeficiency syndrome	5.39e-05	0.000576	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	5.38e-05	0.000575	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	5.34e-05	0.000571	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	5.3e-05	0.000567	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	5.16e-05	0.000552	CbGpPWpGaD
Pranlukast—NFKB1—Toll Like Receptor 4 (TLR4) Cascade—IL6—acquired immunodeficiency syndrome	5.07e-05	0.000542	CbGpPWpGaD
Pranlukast—TNF—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	5.01e-05	0.000536	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—IFNG—acquired immunodeficiency syndrome	4.99e-05	0.000534	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—MBL2—acquired immunodeficiency syndrome	4.96e-05	0.000531	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	4.91e-05	0.000525	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—TNF—acquired immunodeficiency syndrome	4.86e-05	0.00052	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	4.85e-05	0.000518	CbGpPWpGaD
Pranlukast—TNF—TNF alpha Signaling Pathway—IL6—acquired immunodeficiency syndrome	4.84e-05	0.000517	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	4.72e-05	0.000505	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—CD40LG—acquired immunodeficiency syndrome	4.57e-05	0.000489	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of toll-like receptor signaling pathway—IL6—acquired immunodeficiency syndrome	4.57e-05	0.000488	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—HLA-B—acquired immunodeficiency syndrome	4.53e-05	0.000484	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—CD8A—acquired immunodeficiency syndrome	4.52e-05	0.000483	CbGpPWpGaD
Pranlukast—NFKB1—Toll-Like Receptors Cascades—IL6—acquired immunodeficiency syndrome	4.51e-05	0.000483	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	4.5e-05	0.000481	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	4.5e-05	0.000481	CbGpPWpGaD
Pranlukast—TNF—Toll-like Receptor Signaling Pathway—IL6—acquired immunodeficiency syndrome	4.46e-05	0.000476	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	4.44e-05	0.000475	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—IL2—acquired immunodeficiency syndrome	4.44e-05	0.000474	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	4.43e-05	0.000473	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	4.39e-05	0.000469	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	4.36e-05	0.000466	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—HLA-B—acquired immunodeficiency syndrome	4.35e-05	0.000465	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	4.3e-05	0.000459	CbGpPWpGaD
Pranlukast—NFKB1—Myometrial Relaxation and Contraction Pathways—IL6—acquired immunodeficiency syndrome	4.18e-05	0.000447	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	4.18e-05	0.000447	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	4.18e-05	0.000447	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	4.16e-05	0.000445	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	4.07e-05	0.000435	CbGpPWpGaD
Pranlukast—IL5—Immune System—IFNG—acquired immunodeficiency syndrome	4.01e-05	0.000429	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	3.99e-05	0.000427	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—IL6—acquired immunodeficiency syndrome	3.97e-05	0.000424	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	3.9e-05	0.000417	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CCR2—acquired immunodeficiency syndrome	3.89e-05	0.000416	CbGpPWpGaD
Pranlukast—IL5—Immune System—CD4—acquired immunodeficiency syndrome	3.87e-05	0.000414	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	3.76e-05	0.000402	CbGpPWpGaD
Pranlukast—TNF—Adipogenesis—IL6—acquired immunodeficiency syndrome	3.67e-05	0.000392	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—IL6—acquired immunodeficiency syndrome	3.62e-05	0.000387	CbGpPWpGaD
Pranlukast—IL5—Immune System—IL2—acquired immunodeficiency syndrome	3.57e-05	0.000381	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IFNA1—acquired immunodeficiency syndrome	3.5e-05	0.000375	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—IL6—acquired immunodeficiency syndrome	3.48e-05	0.000372	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CD79A—acquired immunodeficiency syndrome	3.4e-05	0.000364	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	3.18e-05	0.00034	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	3.17e-05	0.000339	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	3.13e-05	0.000335	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	3.08e-05	0.00033	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.86e-05	0.000306	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.8e-05	0.000299	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.78e-05	0.000297	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CD40LG—acquired immunodeficiency syndrome	2.77e-05	0.000296	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CD8A—acquired immunodeficiency syndrome	2.74e-05	0.000293	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CSF2—acquired immunodeficiency syndrome	2.74e-05	0.000293	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—IL6—acquired immunodeficiency syndrome	2.73e-05	0.000292	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—CD4—acquired immunodeficiency syndrome	2.7e-05	0.000289	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—HLA-B—acquired immunodeficiency syndrome	2.64e-05	0.000282	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—IL6—acquired immunodeficiency syndrome	2.61e-05	0.000279	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	2.6e-05	0.000278	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—IL6—acquired immunodeficiency syndrome	2.56e-05	0.000274	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.52e-05	0.000269	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—TAT—acquired immunodeficiency syndrome	2.47e-05	0.000264	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.37e-05	0.000253	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.37e-05	0.000253	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.3e-05	0.000246	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.29e-05	0.000245	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—AGPS—acquired immunodeficiency syndrome	2.1e-05	0.000225	CbGpPWpGaD
Pranlukast—IL5—Immune System—IL6—acquired immunodeficiency syndrome	2.1e-05	0.000224	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.1e-05	0.000224	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—TNF—acquired immunodeficiency syndrome	2.05e-05	0.000219	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.8e-05	0.000192	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.77e-05	0.00019	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—IL6—acquired immunodeficiency syndrome	1.66e-05	0.000177	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.65e-05	0.000177	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.65e-05	0.000176	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IFNG—acquired immunodeficiency syndrome	1.63e-05	0.000174	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	1.63e-05	0.000174	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.62e-05	0.000173	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CD4—acquired immunodeficiency syndrome	1.57e-05	0.000168	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—IL6—acquired immunodeficiency syndrome	1.46e-05	0.000156	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL2—acquired immunodeficiency syndrome	1.45e-05	0.000155	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	1.39e-05	0.000148	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.35e-05	0.000145	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—IL6—acquired immunodeficiency syndrome	1.26e-05	0.000135	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	9.72e-06	0.000104	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	9.68e-06	0.000103	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.37e-06	0.0001	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL6—acquired immunodeficiency syndrome	8.52e-06	9.11e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.51e-06	5.89e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ALB—acquired immunodeficiency syndrome	4.31e-06	4.61e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	2.84e-06	3.04e-05	CbGpPWpGaD
